knowledge -WSS

knowledge

author：entertainment 2025-09-27 19:29:31 - browse：91146

Balance innovation — Medicare laid out in the greatest detail yet how it will choose which drug prices it will negotiate in its brand-new program, and how it will figure out what the government’s opening offer will be. Adobe

WASHINGTON — Medicare laid out Wednesday in the greatest detail yet how it will choose which drug prices it will negotiate in its brand-new program, and how it will figure out what the government’s opening offer will be.

Democrats outlined some parts of the process in the Inflation Reduction Act that passed Congress last August, but the details of how drugs will be selected and what factors will be considered have been vague until now. Though the actual negotiated prices won’t take effect for years, Medicare officials must announce the first 10 drugs they’ll negotiate over by Sept. 1.

The guidance clarifies that the agency will choose the 50 pharmacy drugs that cost Medicare the most money, based on gross expenditures. If drugs have the same cost to the program, then the one that has been approved longer will be ranked higher.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： ChatGPT in medicine: STAT answers readers' burning questions
Next article： Astellas still sees hope in its gene therapy after four deaths

explore

WSS

Amylyx ALS drug fails trial: Relyvrio patients react with fear, worry

Readout Newsletter: CAR

John Green on his newest strategy for fighting tuberculosis

U.K. considers world's first use of meningitis vaccine to address gonorrhea

How to save health care price transparency rules

EPA limits use of carcinogenic gas for sterilizing medical devices

Wikipedia

knowledge

entertainment

As demand for Covid shots wanes, Moderna seeks its next success

U.K. considers world's first use of meningitis vaccine to address gonorrhea

Tori Bowie and the unacceptable rates of Black maternal death

As AI in medicine takes off, can 'human in the loop' prevent harm?

Trump demands the U.S. pay no more for drugs than other countries … again

How to save health care price transparency rules

Alkermes shareholders re

RaDonda Vaught links Vanderbilt hospital issues to patient death

Hepatitis C has a cure — but many Americans still lack access to it

Hospitals look to new technology to keep health care workers safe

entertainment

PBM reforms clear House panel

First U.S. drug developed to treat liver disease MASH is approved

How many hemophilia patients actually want gene therapy?

Steward Health Care Massachusetts hospitals face fiscal disaster

Why medical students are struggling with mental health

Medicare coverage of Wegovy, once blocked, now looks possible

Wikipedia

hotspot

explore

entertainment